Key Points: In today’s Recommendations for Industry, we discuss the ongoing need for symptom monitoring. Read more below. The CDC will extend its mask-use on
Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP
Key Points: In today’s Recommendations for Industry, we discuss combatting infectious diseases in the world’s “next normal.” Read more below. The pandemic global death rate
Key Points: In today’s Recommendations for Industry, we discuss TAG’s weekly COVID matrix and its indicators for endemic vs. pandemic and related masking requirements. Read
Key Points: In today’s Recommendations for Industry, we discuss how businesses can assess risk when considering lifting of COVID protections, including masking. Read more below.
Key Points: In today’s Recommendations for Industry, we discuss how COVID-19 has impacted other areas of public health. Read more below. In the U.S., new
Key Points: In today’s Recommendations for Industry, we discuss the continued decline of COVID and the lessons it continues to impart for infectious disease (and
Key Points: In today’s Recommendations for Industry, we discuss the current “transition” status of COVID-19, mask mandates, and recommendations. Read more below. Is the Coronavirus
Key Points: In today’s Recommendations for Industry, we discuss TAG’s matrix and the current trends of COVID and its variants. Read more below. As countries
Key Points: In today’s Recommendations for Industry, we discuss the current progression of COVID and the flu and why keeping calm is the phrase of
